COMMUNIQUÉS West-GlobeNewswire

Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
25/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
25/08/2026
Recognition highlights Truvaga’s combination of patented non-invasive vagus nerve stimulation technology, thoughtful design and personalized wellness experience ROCKAWAY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- [...]
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
25/08/2026
Company on track to initiate SOTERIA trial in the second half of 2026 Clinical development activities advancing following FDA authorization, CRO engagement and Fast Track Designation across all four planned indication [...]
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
25/08/2026
PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between Drug Metabolite [...]
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
25/08/2026
Average Weekly New Patient Referrals into Vivos’ Nevada Sleep & Airway Medicine Centers Rose 212% Over the Past Six Weeks from the Prior Six Weeks LITTLETON, Colo., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Vivos [...]
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
25/08/2026
Updated analysis of 222-patient randomized controlled trial demonstrates statistically significant improvement in complete diabetic foot ulcer closure with XWRAP plus standard of care SCOTTSDALE, Ariz., Aug. 25, 2026 ( [...]
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
25/08/2026
President & CEO, Sabrina Martucci Johnson, discusses the Company’s shift to commercial stage, upcoming revenue opportunities, Ovaprene’s positive interim Phase 3 results and what could drive value over the next 12– [...]
Olympia Pharmaceuticals Introduces Polidocanol 2% Injection for Targeted Cosmetic Vein Treatment
25/08/2026
New injection gives healthcare providers a comfortable, effective option for cosmetic spider and reticular vein therapies ORLANDO, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a premier FDA- [...]
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
25/08/2026
Human studies show that the TGF-β trap and IL-15 fusion used alone promotes expansion of progenitor CD8 + T cells and NK cells Company has incorporated the TGF-β/IL-15 moiety into the constructs of its second-generation [...]
Genmab to Participate in Upcoming Investor Conferences
25/08/2026
Media Release COPENHAGEN, Denmark; August 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that members of its E xecutive Committee will participat e in fireside chats at the following investor conferences in [...]
23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
25/08/2026
Reddick, a 13-time NASCAR Cup Series winner and 2026 Daytona 500 Champion, shares how prioritizing sleep health is an important part of his recovery and performance routine SAN DIEGO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- [...]
Standard Process Launches GI Soothing Supplement for Dogs and Cats
25/08/2026
New probiotic, postbiotic, and botanical formula provides comprehensive gastrointestinal support during periods of digestive upset or distress A Media Snippet accompanying this announcement is available by clicking on [...]
Investors and Entrepreneurs Agree: AI, Enterprise Demand and Investor Confidence Are Reshaping Pharma Tech, According to New McKesson Ventures Report
25/08/2026
Top healthcare investors and entrepreneurs weigh in on priorities, challenges and the direction of innovation across the pharmaceutical value chain SAN FRANCISCO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pharma technology is [...]
From Margaritas to Medicine: Construction Advances at Ally Medical ER Liberty Hill
25/08/2026
The more than 8,000-square-foot facility takes shape on State Highway 29 in the former home of a beloved local Tex-Mex restaurant. LIBERTY HILL, Texas, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Liberty Hill families will soon [...]
10X Health Expands its Flagship Genetic Test to Now Analyze 27 Genes, Providing the Most Comprehensive Methylation Panel Available
25/08/2026
The expanded Methylation Genetic Test from 10X Health is available at no additional cost, is paired with a wellness concierge, and provides customized protocols SCOTTSDALE, Ariz., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Today [...]
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
25/08/2026
HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE [...]
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
25/08/2026
Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in front-line GEA Second FDA [...]
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
25/08/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“ CDT ” or the “ Company ”), today announced that it has entered into a SAFE note with Pep'd Inc. (“ Pep'd [...]
Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease
25/08/2026
Heidelberg, Germany, August 25, 2026 – Revier Therapeutics (“Revier” or “the Company”), today announced the closing of a EUR 6 million seed financing and the launch of its operations. The Company has established the [...]

Pages